The 18 analysts offering 1 year price forecasts for NOVN have a max estimate of — and a min estimate of —.
Analyst rating
Based on 26 analysts giving stock ratings to NOVN in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NOVN EPS for the last quarter is 1.75 CHF despite the estimation of 1.64 CHF. In the next quarter EPS is expected to reach 1.64 CHF. Track more of NOVARTIS N financials and stay on top of what is up with the company.
In the next quarter NOVARTIS N revenue is expected to reach 11.48 B CHF. Check out NOVARTIS N revenue and earnings and make informed decisions.
According to analysts, NOVN price target is 104.16 CHF with a max estimate of 121.46 CHF and a min estimate of 84.90 CHF. Check if this forecast comes true in a year, meanwhile watch NOVARTIS N stock price chart and keep track of the current situation with NOVN news and stock market news.
We've gathered opinions of 26 analysts rating NOVN stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.